Psychosexual Disorders and Gender Identity for NEET PG Psychiatry: Erectile Dysfunction, Paraphilias, Gender Dysphoria, MHCA 2017 Ethics

Start Here

🎯 Exam priority: Moderate. Expect: morning erections in psychogenic ED, sex therapy, PDE5 inhibitors with nitrates and alpha-blockers, blue vision, ED as a cardiac warning, the 6-month rule for paraphilic disorder and gender dysphoria, that gender incongruence and cross-dressing are not disorders by themselves, affirming care, and MHCA 2017 protections.

CBME mapping: PS 9.1–9.2 — psychosexual disorders and the medico-legal, ethical and humanitarian principles for the LGBTQA+ community.

Gender dysphoria, paraphilias and erectile dysfunction: when each is a disorder; gender-affirming care; ED drugs; MHCA 2017

Gender dysphoria, paraphilias and erectile dysfunction: when each is a disorder; gender-affirming care; ED drugs; MHCA 2017. Drawn by TrackNation.

Erectile Dysfunction

  • Causes: vascular (commonest — atherosclerosis of cavernous arteries with smoking and diabetes), neurological, hormonal, psychological and drugs. Psychogenic ED is often situational (a particular place, time or partner), linked to performance anxiety, stress or depression, and the man has normal nocturnal and morning erections — usually absent in organic ED.

  • Evaluate every man for hormonal, neurological and vascular disease and depression; vasculogenic ED can be the first sign of cardiovascular disease.

  • Treatment: sex therapy is the mainstay for psychogenic ED. PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil): never with nitrates; wait ≥ 4 hours after an alpha-blocker; adverse effects — flushing, headache, dyspepsia, visual changes (blue haze with sildenafil/vardenafil), rarely priapism. Next: vacuum devices, intracavernosal injections, penile prosthesis.

Paraphilias and Gender Identity

  • A paraphilia (atypical sexual interest) is not automatically a disorder. A paraphilic disorder needs intense, persistent arousal for ≥ 6 months plus significant distress or impairment, or harm or potential harm to others (children, non-consenting adults). More than one often coexists.

  • Gender incongruence (ICD-11): marked, persistent mismatch between experienced gender and assigned sex — not a disorder by itself; cross-dressing without distress needs no treatment. Gender dysphoria (DSM-5-TR): distress or impairment from that mismatch — diagnose only when significant and lasting ≥ 6 months; it can appear as early as 2–3 years of age.

  • Treatment aims to relieve distress and help the person adapt — never to dissuade them from their identity: psychotherapy, social transition, gender-affirming hormones (estradiol with spironolactone; testosterone) and surgery, which is linked to better mental health. Discuss fertility preservation first. No hormones or surgery before puberty; GnRH agonists (e.g. leuprolide) may block puberty in early adolescence.

Ethics and the Law (Mental Healthcare Act 2017)

  • Every person has a right to mental healthcare without discrimination on the basis of gender, sex or sexual orientation, religion, caste or class (sections 18 and 21).

  • Mental illness must not be determined by non-conformity with moral, social, cultural, work or political values or religious beliefs of the community (section 3).

  • People with mental illness have a right to confidentiality (section 23); informed consent must be free of force, undue influence, fraud or threat and given after adequate information.

Traps the Examiner Sets

  • Morning erections present → psychogenic ED.

  • PDE5 inhibitor + nitrate = contraindicated.

  • Gender incongruence and cross-dressing are not disorders unless they cause distress.

  • "Conversion" of identity is not treatment — affirm and support.

Memory Hooks & Shortcuts

Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.

  • 🧠 'Morning glory = mind problem' — preserved morning erections point to psychogenic ED — ED

  • 🧠 'Nitrate + sildenafil = never' — drug safety

  • 🧠 'Different isn't disorder' — paraphilia, incongruence and cross-dressing need distress or harm — definition rule

  • 🧠 Six-month rule: paraphilic disorder and gender dysphoria — timing

  • 🧠 MHCA: 'no Discrimination, no Diagnosis by Dissent, Discretion (confidentiality)' — law

Rapid-Revision Cards

  • Commonest ED cause

    Vascular (atherosclerosis).

  • Psychogenic ED

    Situational; morning erections normal.

  • ED and heart

    Vasculogenic ED may precede CVD.

  • Psychogenic ED Rx

    Sex therapy.

  • PDE5 inhibitors

    Sildenafil, tadalafil, vardenafil.

  • PDE5 + nitrates

    Contraindicated.

  • Alpha-blocker

    Wait ≥ 4 h.

  • Blue haze

    Sildenafil, vardenafil.

  • Second line ED

    Vacuum, injection, prosthesis.

  • Paraphilic disorder

    ≥ 6 months + distress or harm.

  • Paraphilia alone

    Not a disorder.

  • Gender incongruence

    ICD-11; not a disorder itself.

  • Gender dysphoria

    Distress ≥ 6 months.

  • Cross-dressing

    No distress = no disorder.

  • Treatment aim

    Adapt, never dissuade.

  • Transwomen

    Estradiol + spironolactone.

  • Transmen

    Testosterone.

  • Before hormones

    Fertility preservation.

  • Puberty blockers

    GnRH agonists (leuprolide).

  • MHCA s.18, 21

    No discrimination incl. sexual orientation.

  • MHCA s.3

    No diagnosis by non-conformity.

Sources

Facts in this article were checked against these documents.

  • MSD Manual Professional: Erectile Dysfunction; Overview of Paraphilias and Paraphilic Disorders; Gender Incongruence and Gender Dysphoria — Merck & Co. (MSD Manuals), reviewed 2025–26 (link)

  • The Mental Healthcare Act, 2017 (Act No. 10 of 2017) — Gazette of India, Ministry of Law and Justice, 2017 (link)

  • Competency Based Undergraduate Curriculum, Psychiatry (PS 9) — National Medical Commission, 2024

Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

Practice Questions (NEET PG pattern)

Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.

Q1. A man has erectile failure only with his new partner but normal morning erections. The likely type is

  • (a) vasculogenic ED

  • (b) neurogenic ED

  • (c) psychogenic ED

  • (d) endocrine ED

Show answer

Answer: (c) — Situational; nocturnal erections preserved.


Q2. The most common vascular cause of erectile dysfunction is

  • (a) venous leak only

  • (b) trauma

  • (c) Peyronie disease

  • (d) atherosclerosis of the cavernous arteries

Show answer

Answer: (d) — Smoking, diabetes.


Q3. A 50-year-old smoker develops new erectile dysfunction of vascular type. An important next step is to

  • (a) reassure

  • (b) evaluate for undiagnosed cardiovascular disease

  • (c) start sex therapy only

  • (d) check prolactin only

Show answer

Answer: (b) — ED can be the first sign.


Q4. The mainstay of treatment for psychogenic ED is

  • (a) penile prosthesis

  • (b) testosterone

  • (c) sex therapy

  • (d) vacuum device

Show answer

Answer: (c) — PDE5 inhibitors may help too.


Q5. Sildenafil is absolutely contraindicated in a man who uses

  • (a) statins

  • (b) metformin

  • (c) nitrates

  • (d) aspirin

Show answer

Answer: (c) — Dangerous hypotension.


Q6. A man on tamsulosin wants to use a PDE5 inhibitor. He should

  • (a) take both together

  • (b) wait at least 4 hours after the alpha-blocker and start low

  • (c) use nitrates instead

  • (d) stop tamsulosin permanently

Show answer

Answer: (b) — Risk of hypotension.


Q7. A bluish tinge to vision after taking an ED drug is typical of

  • (a) alprostadil

  • (b) sildenafil or vardenafil

  • (c) testosterone

  • (d) tadalafil only

Show answer

Answer: (b) — Blue haze.


Q8. If oral PDE5 inhibitors fail or are not tolerated, options include

  • (a) SSRIs

  • (b) nitrates

  • (c) vacuum devices, intracavernosal injections or penile prosthesis

  • (d) antipsychotics

Show answer

Answer: (c) — Per MSD.


Q9. Every man with ED should be evaluated for hormonal, neurological and vascular disorders and

  • (a) autism

  • (b) OCD

  • (c) depression

  • (d) schizophrenia

Show answer

Answer: (c) — Psychological causes.


Q10. An atypical sexual interest becomes a paraphilic disorder only when it is intense and persistent and

  • (a) is unusual

  • (b) occurs once

  • (c) lasts ≥ 6 months with distress, impairment or harm to others

  • (d) involves fantasy only

Show answer

Answer: (c) — Interest alone is not a disorder.


Q11. Which statement about paraphilias is correct?

  • (a) having a paraphilic interest is not by itself a disorder

  • (b) every paraphilia is a disorder

  • (c) they are always illegal

  • (d) they never co-occur

Show answer

Answer: (a) — Per MSD.


Q12. People with one paraphilic disorder often

  • (a) have more than one

  • (b) never have another

  • (c) have schizophrenia

  • (d) are always women

Show answer

Answer: (a) — Per MSD.


Q13. Gender dysphoria is defined by

  • (a) distress or impairment from a mismatch between gender identity and assigned gender

  • (b) sexual orientation

  • (c) cross-dressing

  • (d) the identity itself

Show answer

Answer: (a) — Distress defines it.


Q14. Gender dysphoria should be diagnosed only when significant distress or impairment persists for at least

  • (a) 2 weeks

  • (b) 6 months

  • (c) 5 years

  • (d) 1 month

Show answer

Answer: (b) — Per MSD.


Q15. In ICD-11, a marked and persistent mismatch between experienced gender and assigned sex is called

  • (a) paraphilia

  • (b) transvestism

  • (c) gender identity disorder

  • (d) gender incongruence

Show answer

Answer: (d) — Not in the mental disorders chapter.


Q16. A man occasionally cross-dresses, feels comfortable and has no distress or impairment. He

  • (a) needs aversion therapy

  • (b) needs hormone therapy

  • (c) has gender dysphoria

  • (d) has no disorder and needs no treatment

Show answer

Answer: (d) — No distress = no disorder.


Q17. The aim of treatment in gender dysphoria is to

  • (a) stop transition

  • (b) relieve distress and help the person adapt, not dissuade them from their identity

  • (c) prescribe antipsychotics

  • (d) change their identity

Show answer

Answer: (b) — Affirming care.


Q18. Gender-affirming hormone therapy for transwomen typically uses

  • (a) oestradiol with spironolactone

  • (b) testosterone

  • (c) progesterone alone

  • (d) finasteride alone

Show answer

Answer: (a) — Transmen: testosterone.


Q19. Before gender-affirming hormones or surgery, clinicians should discuss

  • (a) nothing

  • (b) fertility preservation

  • (c) only surgery

  • (d) only cost

Show answer

Answer: (b) — Fertility may be impaired.


Q20. Hormones or surgery for gender dysphoria in prepubertal children are

  • (a) first line

  • (b) standard care

  • (c) not recommended by any guideline

  • (d) required by law

Show answer

Answer: (c) — Puberty blockers may be used in early adolescence.


Q21. Puberty blockers used in early adolescence are

  • (a) GnRH agonists such as leuprolide

  • (b) antiandrogens alone

  • (c) SSRIs

  • (d) corticosteroids

Show answer

Answer: (a) — Block sex hormone production.


Q22. Gender-affirming surgery in people with gender dysphoria is associated with

  • (a) improved mental health outcomes

  • (b) psychosis

  • (c) worse mental health

  • (d) no change

Show answer

Answer: (a) — Per MSD.


Q23. Childhood gender dysphoria can manifest as early as

  • (a) 2–3 years

  • (b) 10 years

  • (c) adulthood only

  • (d) 16 years

Show answer

Answer: (a) — Per MSD.


Q24. Under the Mental Healthcare Act 2017, mental healthcare must be provided without discrimination on the basis of

  • (a) nothing specified

  • (b) income only

  • (c) gender, sex and sexual orientation, among others

  • (d) age only

Show answer

Answer: (c) — Sections 18 and 21.


Q25. A family brings their son to a psychiatrist because he is gay and they want him 'treated'. Under MHCA 2017,

  • (a) he must be admitted

  • (b) mental illness cannot be determined by non-conformity with social or moral values

  • (c) he must be given ECT

  • (d) the doctor must inform the police

Show answer

Answer: (b) — Section 3.


Q26. MHCA 2017 gives a person with mental illness the right to

  • (a) free surgery

  • (b) no information

  • (c) compulsory treatment

  • (d) confidentiality about their mental health and treatment

Show answer

Answer: (d) — Section 23.


Q27. Under MHCA 2017, valid informed consent must be

  • (a) assumed in emergencies always

  • (b) verbal only

  • (c) obtained from the police

  • (d) given for a specific intervention without force, undue influence, fraud or threat

Show answer

Answer: (d) — After adequate information.


Q28. PDE5 inhibitors can rarely cause

  • (a) hyperkalaemia

  • (b) seizures

  • (c) hypertension crisis

  • (d) priapism

Show answer

Answer: (d) — Plus flushing, headache, dyspepsia.


Q29. Psychological causes of secondary ED include

  • (a) atherosclerosis

  • (b) spinal injury

  • (c) hyperprolactinaemia

  • (d) performance anxiety, stress or depression

Show answer

Answer: (d) — Often mixed with organic causes.


Q30. The main gender-affirming drug for transmen is

  • (a) oestradiol

  • (b) leuprolide only

  • (c) testosterone

  • (d) spironolactone

Show answer

Answer: (c) — Per MSD.

Active Recall

From memory: distinguish psychogenic from organic erectile dysfunction and outline treatment and PDE5 inhibitor safety, state when a paraphilia or gender incongruence becomes a disorder, describe gender-affirming care, and list the MHCA 2017 protections.